New Delhi, Dec. 10 -- The IPO of Corona Remedies has witnessed a sharp rise in investor interest, especially from institutional participants, during the final day of bidding, which pushed the subscription rate to over 144 times.

The issue, which opened on Monday, December 08, closed today, and during the three-day bidding period, it attracted bids for 62.67 crore shares against over 43.36 lakh shares on offer, resulting in a subscription rate of 144.4 times, as per exchange data.

The qualified institutional buyer (QIB) segment saw a strong spike in demand, with the quota being subscribed 293.80 times, while the non-institutional investor (NII) portion was subscribed 220 times, and the retail investor portion was subscribed 30.39 times. ...